Category: Schizophrenia

Studies Enrolling at Lincoln Research — July 2016

cropped-lincolncoverGW1.jpg

Lincoln Research is looking for volunteers for several studies exploring different conditions and treatment options. Here are some of the studies we’re conducting right now. This list changes often, so make sure to like us on Facebook or subscribe to our newsletter for updates.

Migraine Studies

We have two different studies looking for volunteers who suffer from migraine headaches. Information on both is here:

Migraine fixed

Spartan

Bipolar Disorder

We’re also looking for patients with Bipolar Disorder for a study. Information is here:

Bipolar

Depression

We’re looking for subjects with depression (Major Depressive Disorder) to volunteer for a new study. You can find more information on our website or check out depression resources on our blog, here.

Schizophrenia

For our study on schizophrenia, we’re interested in speaking to people who suffer from schizophrenia, caretakers of patients with schizophrenia, and clinicians who treat patients with schizophrenia. You can find more information on our website or call at (401) 305-5200.

If interested in participating in a study, call (401) 305-5200 or contact us using our web form.

Current Studies at Lincoln Research

leadingresearch

Lincoln Research is a clinical research site dedicated to high-quality patient care. We specialize in research of psychiatric conditions such as Major Depressive Disorder (MDD), but have conducted studies in a wide variety of areas. If you’re interested in participating in a study, but none of our current studies interest you, be sure to check back in on our study listings page every couple of months to see what’s new.

Here are the studies we have going right now.

Migraine

Migraine fixed

Schizophrenia>

Are you or a loved one currently taking Invega Sustenna (paliperidone palmitate) for the treatment of schizophrenia and not having an adequate response?

This study is investigating whether a newly FDA-approved medicine may provide adequate treatment for your symptoms of schizophrenia

To be eligible for this study, you must:

  • Be 18 to 65 years of age
  • Have a diagnosis of schizophrenia
  • Have received at least 3 doses of Invega Sustenna (paliperidone palmitate) prior to the study

Call our office to see if this clinical trial may be appropriate for you!

Genetic Testing for Depression

AssureRx

To stay updated with information about new opportunities at Lincoln Research, like us on Facebook or subscribe to our monthly newsletter.

Powered by WordPress & Theme by Anders Norén